Argent Biopharma (ASX:RGT)
ASX announcement history & article coverage
Transparent by design.
Announcments by Argent Biopharma (ASX:RGT) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Application for quotation of securities - RGT
RGT Executes Global CannEpil Licensing Deal for US$5.5M
Argent BioPharma licenses CannEpil® globally to Splash Beverage for US$5.5M upfront and 15% royalties
Long Term Aquiol Licensing and Supply Agreement
Argent BioPharma inks exclusive 5-year Aquiol™ licensing deal with MGC Derma for global dermatology cosmetics
Final Director's Interest Notice - GH
Initial Director's Interest Notice - AC
Appointment of Executive Director
Quarterly Activities/Appendix 4C Cash Flow Report
Argent BioPharma expands portfolio with CannPal acquisition, ships largest CannEpil order to Ireland, and files US patent for NanoBodies platform
